HEALIUS LIMITED — Director's Dealing 2022

Sep 12, 2022

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entityHEALIUS LIMITED	Name of entityHEALIUS LIMITED
ABN	24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	John Mattick
Date of last notice	31 March 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [444 x 322] intentionally omitted <==

----- Start of picture text ----- Direct or indirect interest IndirectNature of indirect interest(including registered holder) As shownNote: Provide details of the circumstances givingrise to the relevant interest.Date of change 09 September 2022No. of securities held prior toNilchangeClass Fully paid Ordinary SharesNumber acquired 19,230Number disposed N/AValue/ConsiderationNote: If consideration is non-cash, provide details $3.648 per shareand estimated valuationNo. of securities held after19,230 Ordinary Shares J & L Mattick Retirement Fundchange----- End of picture text -----

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under On-market trade dividend reinvestment plan, participation in buyback

Part 2 – Change of director’s interests in contracts Not applicable

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written N/A clearance was required? If so, was prior written clearance provided to allow the N/A trade to proceed during this period? If prior written clearance was provided, on what date was N/A this provided?

Authorised by the Company Secretary.

Charles Tilley Company Secretary Date: 13 September 2022

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011